The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced a new potency-labelling system for topical steroids to guide selection and simplify patient counselling.
Please provide your email address to receive an email when new articles are posted on . Steroid-induced glaucoma was more likely with at least 6 months of use, higher potency and urban residence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback